1,036 research outputs found

    Medical history among Bulgarian patients with fever of unknown origin and low-grade fever

    Get PDF
    Въведение: Персистиращият фебрилитет с неизвестен произход е предизвикателство пред медицинската общност. Целта на тази статияе да се представят анамнестичните данни при български пациенти с неясно фебрилно състояние (НФС) и субфебрилна температура.Материали и методи: За периода от 01.02.2012г. до 01.08.2015г. в Клиниката по инфекциозни болести към ВМА-София се проведе проспективно проучване на пациенти с НФС и субфебрилитет. Изследвани бяха общо 117 пациенти, от тях с НФС - 88 човека, със субфебрилитет 29 човека. В настоящата работа са използвани следните методи: библиографски метод, метод на сравнението и клинични методи.Резултати: Основните анамнестични данни, имащи принос към поставянето на окончателната диагноза при всички проучени пациенти, са следните - умора, изпотяване, втрисане, главоболие и артралгия.Заключение: Анамнезата е от съществено значение за крайния успех в диагностиката на фебрилитета с неизвестен произход. Тя се явява първа стъпка в диагностичния алгоритъм при НФС.Introduction: The persisting fever of indeterminate genesis is a challenging for the medical society. The aim of this paper was to present the medical history of Bulgarian patients with fever of unknown origin (FUO) and low-grade fever (non-FUO).Materials and methods: A prospective study of patients with FUO and non-FUO was done at the Department of Infectious Diseases, Military Medical Academy (Sofia, BG) for the period: 1st February 2012 - 1st August 2015. A population of 117 patients were analyzed, 88 - FUO, 29 - non-FUO. The following methods were applied: literature review, a method of comparison and clinical evaluation.Results: The main historical data which are leading to the final diagnosis in the whole analyzed group were: fatigue, sweats, chills, headache and arthralgia.Conclusion: The medical history is a basic key in the diagnostic pathway to the final diagnosis in case of fever of undetermined origin. This is the first step in the diagnostic algorithm

    Infekcija virusom Zapadnog Nila s neurološkim poremećajima: prikaz slučaja i kratak pregled stanja u Bugarskoj

    Get PDF
    A case of a 66-year-old man with West Nile neuroinvassive disease manifested with fever, weakness, fa-tigue, consciousness disorders and underlying diabetes mellitus type 2 and cardiovascular diseases is pre-sented. Laboratory data showed elevated erythrocyte sedimentation rate and fibrinogen. Serological tests revealed West Nile virus specific antibodies of class IgM and IgG in serum. West Nile virus RNA was de-tected in urine sample. Supportive therapy was applied.Prikazuje se slučaj 66-godišnjeg bolesnika s neuroinvazivnom bolešću Zapadnog Nila koja se manifestirala grozni-com, umorom, poremećajem svijesti uz osnovnu bolest dijabetesa tipa 2 i kardiovaskularnom bolešću. Laboratorij-ski podaci pokazali su povišenu sedimentaciju i fibrinogen. Serološki testovi utvrdili su protutijela specifična za virus Zapadnog Nila klase IgM i IgG u serumu. Virusna RNA otkrivena je u uzorku mokraće. Primijenjena je suportivna terapija

    Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII

    Get PDF
    Abstract\ud \ud \ud \ud Background\ud \ud Hemophilia A is a bleeding disorder caused by deficiency in coagulation factor VIII. Recombinant factor VIII (rFVIII) is an alternative to plasma-derived FVIII for the treatment of hemophilia A. However, commercial manufacturing of rFVIII products is inefficient and costly and is associated to high prices and product shortage, even in economically privileged countries. This situation may be solved by adopting more efficient production methods. Here, we evaluated the potential of transient transfection in producing rFVIII in serum-free suspension HEK 293 cell cultures and investigated the effects of different DNA concentration (0.4, 0.6 and 0.8 μg/106 cells) and repeated transfections done at 34° and 37°C.\ud \ud \ud \ud Results\ud \ud We observed a decrease in cell growth when high DNA concentrations were used, but no significant differences in transfection efficiency and in the biological activity of the rFVIII were noticed. The best condition for rFVIII production was obtained with repeated transfections at 34°C using 0.4 μg DNA/106 cells through which almost 50 IU of active rFVIII was produced six days post-transfection.\ud \ud \ud \ud Conclusion\ud \ud Serum-free suspension transient transfection is thus a viable option for high-yield-rFVIII production. Work is in progress to further optimize the process and validate its scalability.The authors would like to acknowledge FAPESP (2008/51505-7) and FINEP (01.07.0652.00) for financial support
    corecore